BioScience Health Innovations, Inc. (BHIC) stock: key figures, P/E, revenue and dividend
Information Technology · United States
BioScience Health Innovations, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 5.69 m USD |
| Gross profit | 3.24 m USD |
| Operating income | 719,051.00 USD |
| EBIT | 719,051.00 USD |
| Net income | 642,090.00 USD |
| Diluted EPS – continuing operations | 0.06 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BioScience Health Innovations, Inc.
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.
More stocks
- Kapsch Traffic (KTCG.VI)
- Sam-A Pharm. Co. Ltd (009300.KQ)
- Korea Business News Co. Ltd (039340.KQ)
- Northeast Indiana Bancorp Inc (NIDB)
- Hwacheon Mac (000850.KS)
- Celemics Inc (331920.KQ)
- iNtRON Biotechnology Inc (048530.KQ)
- THiRA-UTECH CO. LTD (322180.KQ)
- Spero Therapeutics, Inc. (SPRO)
- Autocount Dotcom Berhad (0276.KL)
- Emperor Energy Ltd (EMP.AX)
- TECO Image Systems Co Ltd (5438.TWO)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.